MoneyWorks4Me

Pharmaids Pharmaceuticals informs about issuance of duplicate share certificate

05 Jul 2023 Evaluate

Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Pharmaids Pharmaceuticals has informed that the Company has received the intimation letter from its Registrars & Share Transfer Agent of the Company, Venture Capital and Corporate Investments., regarding the duplicate share certificates of the Company that have been issued, the details of which are enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..